ROGER SCHLEMMER, M.D.

M.D.

Ophthalmology Physician

NPI: 1891072963Individual

Specialties, Licenses & Credentials

Ophthalmology PhysicianPrimary

Ophthalmology

Code: 207W00000X

2005031082(MO)04-14238(KS)

Research & Publications (10)

Detection of ketamine and norketamine in urine of nonhuman primates after a single dose of ketamine using microplate enzyme-linked immunosorbent assay (ELISA) and NCI-GC-MS.

PMID 15842758·J Anal Toxicol·2005

7-preclinical

[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) complexes, compounds for the endocrine therapy of breast cancer - mode of action II: contribution of drug inactivation, cellular drug uptake and sterical factors in the drug-target interaction to the antitumor activity.

PMID 15188224·Arch Pharm (Weinheim)·2004

4-observational

[1, 2-Bis(2, 6-difluoro-3-hydroxyphenyl)ethylene-diamine]platinum(II) complexes, compounds for the endocrine therapy of breast cancer - mode of action I: antitumor activity due to the reduction of the endogenous estrogen level.

PMID 15188223·Arch Pharm (Weinheim)·2004

4-observational

Establishment and characterization of new murine breast cancer cell lines.

PMID 12043456·Arch Pharm (Weinheim)·2002

7-preclinical

Establishment and Characterization of New Murine Breast Cancer Cell Lines.

PMID 12007108·Arch Pharm (Weinheim)·2002

8-other

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) act as an immune response modifier? IV. Inhibition of the proliferation-increasing effect of progressively growing MXT-M-3,2 breast cancer on phagocytes by the title compound.

PMID 11759169·Arch Pharm (Weinheim)·2001

7-preclinical

1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes--new biological response modifiers for the therapy of breast cancer. Synthesis and evaluation of estrogenic/antiestrogenic properties.

PMID 11382148·Arch Pharm (Weinheim)·2001

7-preclinical

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloro-platinum(II) act as an immune response modifier? Part III: Progressively growing MXT-M-3,2 breast cancer stimulates the proliferation of phagocytes in B6D2F1 mice.

PMID 11199470·Arch Pharm (Weinheim)·2000

7-preclinical

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) on the specific immune defense in MXT-M-3,2 breast cancer bearing mice.

PMID 11199469·Arch Pharm (Weinheim)·2000

7-preclinical

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part 1: The MXT-M-3.2 breast cancer stimulates the growth of an identical second graft; [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplat inum (II) inhibits this process.

PMID 10783521·Arch Pharm (Weinheim)·2000

7-preclinical

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address: 2733 EAST BATTLEFIELD RD., #106
SPRINGFIELD, MO 65804
Phone: (417) 887-5544

Location

Practice Location

2733 EAST BATTLEFIELD RD., SPRINGFIELD, MO

Quick Facts

NPI: 1891072963
Entity Type: Individual
Gender: Male
Medicare: Not confirmed
Specialties: 2
Locations: 1
Publications: 10

Are you this provider?

Claim Your Profile